---

According to Regulation (EC) No 1907/2006 (REACH) and Regulation (EC) No 1272/2008 (CLP) as retained in UK law

1. Identification

1.2 Relevant identified uses of the substance and uses advised against

For research use only (in vitro). Not for human or veterinary use, including diagnostic, therapeutic, prophylactic or in vivo administration of any kind. Not for use in or as a food, drug, medical device, cosmetic, household product, or any other commercial application.

1.3 Details of the supplier of the Safety Data Sheet

N9 BIOTECH

Nimbus9 Group Limited
Company Number: 17199136

124 City Road
London
England
EC1V 2NX
United Kingdom

Email: support@n9biotech.uk
Website: www.n9biotech.uk
Business Hours: Monday-Friday 09:00-17:30 GMT/BST

1.4 Emergency telephone number

Emergency services (UK): 999

For medical emergencies involving chemical exposure, healthcare professionals may consult the National Poisons Information Service (NPIS).

2. Hazard(s) identification

2.1 Classification of the substance or mixture

Based on available data and supplier assessment in accordance with UK CLP (Regulation (EC) No 1272/2008 as retained in Great Britain), this substance does not meet the criteria for classification as hazardous.

2.2 Label elements

• Hazard pictograms: None
• Signal word: None
• Hazard statements (H-codes): None
• Precautionary statements (P-codes): None

2.3 Other hazards

PBT/vPvB assessment: Not applicable. The substance has not been assessed as Persistent, Bioaccumulative and Toxic (PBT) or very Persistent and very Bioaccumulative (vPvB).

No other hazards known under conditions of normal handling. As a research-use-only substance with limited published toxicological data, handle with the precautions appropriate to a substance of unknown toxicity.

3. Composition / information on ingredients

Substance type: Substance (single component)

4. First-aid measures

4.1 Description of first-aid measures

4.2 Most important symptoms and effects, acute and delayed

No specific symptoms known. As a research compound with limited toxicological characterisation, observe casualty for delayed effects.

4.3 Indication of any immediate medical attention and special treatment needed

Treat symptomatically. No specific antidote is known.

5. Fire-fighting measures

6. Accidental release measures

Personal precautions: Wear appropriate personal protective equipment (see section 8). Avoid generation and inhalation of dust. Avoid contact with skin and eyes.

Environmental precautions: Do not allow to enter drains, sewers, or watercourses.

Containment: Collect spilled material into a sealable, labelled container. Avoid dust generation.

Cleaning up: After collection, wash the spill area with water. Dispose of waste in accordance with section 13.

7. Handling and storage

7.1 Precautions for safe handling

Handled only in a properly ventilated laboratory by trained personnel. Avoid formation of dust and aerosols. Avoid contact with skin, eyes and clothing. Wash thoroughly after handling. Do not eat, drink or smoke when using this product.

7.2 Conditions for safe storage, including any incompatibilities

Store the unopened, lyophilised product at -20°C protected from light and moisture, in the original sealed container. Prepared solutions should be stored according to validated laboratory procedures.

Incompatibilities: Strong oxidising agents, strong acids and strong bases. Avoid prolonged exposure to atmospheric moisture (hygroscopic).

7.3 Specific end uses

For research use only (in vitro). See section 1.2.

8. Exposure controls / personal protection

8.1 Control parameters

No occupational exposure limits (WELs, OELs, TLVs) have been established for this substance.

8.2 Exposure controls

9. Physical and chemical properties

10. Stability and reactivity

11. Toxicological information

11.1 Information on toxicological effects

No specific toxicological data is available for this substance. Limited toxicological data is available and the precautionary principle should be applied.

12. Ecological information

13. Disposal considerations

13.1 Waste treatment methods

Product waste: Dispose of contents and container in accordance with UK Environmental Protection Act 1990, Hazardous Waste (England and Wales) Regulations 2005 (as amended), and any other relevant national, regional and local legislation. Consult a licensed waste disposal contractor.

Contaminated packaging: Empty containers should be disposed of in line with local regulations. Do not reuse empty containers.

EWC waste code: Not assigned by the supplier. The end user must allocate a List of Wastes (LoW) code formerly European Waste Catalogue (EWC) - appropriate to the specific use and waste stream.

14. Transport information

Environmental hazards: Not applicable
Special precautions for user: None
Transport in bulk (MARPOL): Not applicable - substance is not transported in bulk

15. Regulatory information

UK REACH: Regulation (EC) No 1907/2006 as it applies in Great Britain by virtue of the REACH etc. (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/758), as amended. This substance is not listed on the UK REACH Candidate List of Substances of Very High Concern (SVHC) and is not subject to authorisation under UK REACH Annex XIV.

UK CLP: Regulation (EC) No 1272/2008 as it applies in Great Britain by virtue of the CLP etc. (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/720), as amended. The substance does not have a harmonised classification under UK CLP Annex VI and is not classified by the supplier as hazardous.

MHRA: This product is not authorised as a medicinal product by the UK Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012. Any supply, marketing, or use must comply with applicable UK legislation, including the Human Medicines Regulations 2012. This product is supplied solely as a chemical reagent for in vitro research.